Stock listing
TPEx:7871 Elixiron Immunotherapeutics (Cayman) Limited (安立璽榮-KY) 股價
Follow Elixiron Immunotherapeutics (Cayman) Limited into a list and get an email when it puts out news.
- Ticker
- TPEx:7871
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
What changed lately
Latest news release · Jun 11, 2026
Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease
Latest deck · Jun 4, 2026
Yuanta Securities Pre-IPO Investor Conference 2026
Conference · 40 slides
Latest news
Decks
Yuanta Securities Pre-IPO Investor Conference 2026
Conference · 40 slides · Jun 4, 2026
Yuanta Securities Investor Conference 2026
Conference · 37 slides · Jun 4, 2026
Elixiron Immunotherapeutics (Cayman) Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 1 in all · newest Jun 11, 2026 · oldest 2026
- Decks
- 2 decks · latest Jun 4, 2026
Log in to ask 6ix AI your own questions about Elixiron Immunotherapeutics (Cayman) Limited.